IE
AHPI

Israel Englander’s Allied Healthcare Products AHPI Stock Holding History

Israel Englander’s Portfolio AHPI Stock Details AHPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,578
Closed -$25K – 7727
2022
Q2 		$25K Buy
+15,578
New +$35.3K ﹤0.01% 6437

Other funds holding AHPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Israel Englander's AHPI Position: Q3 2022 in Review

Israel Englander sold out of Allied Healthcare Products (AHPI) in Q3 2022, closing a stake of 15,578 shares — an estimated $25K sold.

Israel Englander first reported a position in AHPI in Q2 2022 and held it in 1 quarter. The position peaked at $25K in Q2 2022. 12 funds tracked by Wall St. Rank hold AHPI as of Q3 2022.

  • Israel Englander reported no remaining Allied Healthcare Products position as of Q3 2022 after selling out during the quarter.
  • Israel Englander sold 15,578 Allied Healthcare Products shares in Q3 2022, an estimated $25K.
  • Israel Englander first reported a position in Allied Healthcare Products in Q2 2022 and held it in 1 quarter.
  • Israel Englander's Allied Healthcare Products position peaked at $25K in Q2 2022.
  • 12 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.